Clinical Trial Update: Reirradiation Dose Escalation in Thoracic Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating dose escalation of reirradiation in thoracic cancers, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Lung Cancer

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Thoracic Cancer, Lung Cancer | Phase 1 | Status: NOT_YET_RECRUITING